title: Biomaterials and biotechnology: from the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering.
abstract: This paper describes the discovery of the first inhibitors of angiogenesis; the discoveries that led to the development of the first biocompatible controlled release systems for macromolecules, and findings that helped to create the field of tissue engineering. In addition, new paradigms for creating biomaterials, early work on nanotechnology in medicine and intelligent drug delivery systems are discussed.
authors.affiliation: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. rlanger@mit.edu
authors.forename: Robert
authors.initials: R
authors.lastname: Langer
mesh_terms: D020533:Angiogenesis Inhibitors / Q000266:history*; D000818:Animals; D001363:Awards and Prizes; D001672:Biocompatible Materials / Q000266:history; D001709:Biotechnology / Q000266:history; D001900:Boston; D016503:Drug Delivery Systems / Q000266:history*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D050997:Nanomedicine / Q000266:history; D036103:Nanotechnology / Q000266:history; D012958:Societies, Scientific; D023822:Tissue Engineering / Q000266:history
chemical_list: D020533:Angiogenesis Inhibitors; D001672:Biocompatible Materials
keywords: biomaterial; drug delivery; engineering; tissue